Provided by Tiger Trade Technology Pte. Ltd.

Pharvaris N.V.

38.22
-0.6450-1.66%
Volume:604.80K
Turnover:23.40M
Market Cap:2.67B
PE:-12.76
High:40.00
Open:39.12
Low:37.85
Close:38.86
52wk High:43.25
52wk Low:20.65
Shares:69.86M
Float Shares:43.70M
Volume Ratio:0.67
T/O Rate:1.38%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.9943
EPS(LYR):-3.4871
ROE:-70.46%
ROA:-42.32%
PB:7.69
PE(LYR):-10.96

Loading ...

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Pharvaris (PHVS) and Allogene Therapeutics (ALLO)

TIPRANKS
·
May 14

Stock Track | Pharvaris N.V. Soars 5.09% Intraday on Bullish Analyst Ratings

Stock Track
·
May 14

Pharvaris Is Maintained at Market Outperform by Citizens

Dow Jones
·
May 13

Analysts Offer Insights on Healthcare Companies: Pharvaris (PHVS), Neurogene (NGNE) and Stereotaxis (STXS)

TIPRANKS
·
May 13

RBC Capital Reaffirms Their Buy Rating on Pharvaris (PHVS)

TIPRANKS
·
May 13

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 13

Pharvaris price target lowered to $74 from $75 at Citizens

TIPRANKS
·
May 13

Pharvaris Q1 EPS $(0.69) Beats $(0.77) Estimate

Benzinga Earnings
·
May 13

Pharvaris Q1 Loss Narrows

MT Newswires Live
·
May 13

Earnings Flash (PHVS) Pharvaris Posts Q1 Per Share Loss 0.59 Euro, vs. FactSet Est of 0.71 Euro Loss

MT Newswires Live
·
May 13

Switzerland's Pharvaris Q1 loss per share narrows

Reuters
·
May 13

Pharvaris Q1 FY26 loss narrows to €39.2 million

Reuters
·
May 13

Pharvaris N.v. Q1 EPS EUR -0.59

THOMSON REUTERS
·
May 13

Press Release: Pharvaris Reports First Quarter 2026 Financial Results and Provides Business Update

Dow Jones
·
May 13

Pharvaris Raises $124 Million in May Equity Offering to Fund Late-Stage Programs and U.S. Commercial Build-Out

TIPRANKS
·
May 12

Pharvaris closes follow-on offering, raises $132.3 million gross proceeds

Reuters
·
May 12

Press Release: Pharvaris Announces Closing of $132.3 Million Underwritten Offering of Ordinary Shares and Full Exercise of Underwriters' Option to Purchase Additional Shares

Dow Jones
·
May 12

Pharvaris price target raised to $31 from $30 at BofA

TIPRANKS
·
May 10

Analysts Offer Insights on Healthcare Companies: Amylyx Pharmaceuticals Inc (AMLX), BioAge Labs, Inc. (BIOA) and Pharvaris (PHVS)

TIPRANKS
·
May 10

BRIEF-Pharvaris Announces Pricing Of $115 Million Underwritten Offering Of Ordinary Shares

Reuters
·
May 08